BLVRB
BLVRB (biliverdin reductase B, also known as flavin reductase, FLR or SDR43U1) is a cytoplasmic enzyme that acts as an NAD(P)H-dependent reductase and as an S-nitroso-CoA-dependent nitrosyltransferase. It promotes foetal heme degradation and regulates metabolism and insulin signalling in adult tissues. Browse Assay Genie's current range of BLVRB research reagents below, or read on for the biology behind the target.
BLVRB is an enzyme with two documented activities. As an oxidoreductase of broad specificity, it catalyses the NAD(P)H-dependent reduction of a variety of flavins, including riboflavin, FAD and FMN, as well as biliverdins, methemoglobin and PQQ (pyrroloquinoline quinone). It can also reduce complexed Fe(3+) iron to Fe(2+) in the presence of FMN and NADPH. In the foetal liver it contributes to heme catabolism by reducing biliverdin IXbeta, the major foetal heme catabolite, to bilirubin IXbeta. It does not reduce bilirubin IXalpha, and biliverdin IXbeta is not present in the adult.
The second activity is protein nitrosylation. BLVRB acts as an S-nitroso-CoA-dependent nitrosyltransferase through a ping-pong mechanism. It first associates with S-nitroso-CoA and the protein substrate. The nitric oxide group is then transferred to Cys-109 and Cys-188 of BLVRB and on to the substrate. Targets include HMOX2, INSR and IRS1. By nitrosylating INSR and IRS1, BLVRB inhibits insulin signalling. NCBI Gene annotates the same functions, including peptidyl-cysteine S-nitrosylase activity, a role in megakaryocyte differentiation and negative regulation of the insulin receptor signalling pathway.
Although BLVRB promotes foetal heme degradation during development, it is also expressed in adult tissues. There it regulates haematopoiesis and intermediary metabolism, including glutaminolysis, glycolysis, the TCA cycle and the pentose phosphate pathway. The BLVRB gene belongs to the BLVRB family and the short chain dehydrogenase/reductase superfamily, and the protein is classed among the flavoproteins. The enzyme was formerly named flavin reductase, and the mouse ortholog is Blvrb.
BLVRB reduces biliverdin IXbeta to bilirubin IXbeta in the foetal liver, making it a focus for studies of foetal heme degradation.
BLVRB regulates haematopoiesis in adult tissues and is involved in megakaryocyte differentiation.
BLVRB nitrosylates INSR and IRS1 and so inhibits insulin signalling, linking the enzyme to insulin receptor pathway studies.
Through flavin reduction and effects on glycolysis, the TCA cycle and the pentose phosphate pathway, BLVRB informs work on intermediary metabolism.
BLVRB is an NAD(P)H-dependent reductase of flavins, biliverdins, methemoglobin and PQQ, and an S-nitroso-CoA-dependent nitrosyltransferase. It reduces biliverdin IXbeta in foetal heme catabolism and nitrosylates proteins such as HMOX2, INSR and IRS1, inhibiting insulin signalling.
BLVRB stands for biliverdin reductase B. Other names and symbols are flavin reductase (NADPH), FLR and SDR43U1. Earlier names include flavin reductase and biliverdin reductase B (flavin reductase (NADPH)). The enzyme carries EC number 1.5.1.30.
A mouse ortholog, Blvrb, is recorded for the human BLVRB gene. Human BLVRB is assigned to the short chain dehydrogenase/reductase superfamily and the BLVRB family. Check the datasheet of any product for its validated reactivity.
Insulin signalling proteins, heme catabolism enzymes and other flavoprotein reductases related to BLVRB biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P30043; product specifications from Assay Genie datasheets.